• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting

    31-07-2026 | 06:42 pm

    Glenmark Pharma's board greenlit Q1 FY27 consolidated results: Revenue ₹3,931.73 Cr, Net Profit ₹482.92 Cr, EPS ₹17.11. The 48th AGM is on Sep 11, 2026; Aug 31, 2026, is the record date for FY26 dividend. Risk Management Committee leadership updated. #GlenmarkPharma #Q1FY27

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited